MedTrace Logo

Effects of Scapular Therapeutic Exercise on Essential Biomechanical and Neurophysiological Parameters in Shoulder Pain Conditions With Scapular Impairments

NCT05814978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-30

No results posted yet for this study

Summary

Shoulder pain is a prevalent and recurrent condition. After a period of shoulder pain, some adaptations could be found, as in scapular muscles and kinematics and/or in nervous system.

It seems important to assess several biomechanical and neurophysiological outcomes to better characterize shoulder pain conditions and to program an intervention plane.

Therapeutic exercise is one of the treatments used for shoulder pain, however there are still doubts and controversial findings regarding exercise focusing the scapular musculature. Thus, the present study aims to assess the effects of an intervention protocol based on scapular therapeutic exercise.

Conditions

  • Shoulder Pain

Interventions

OTHER

Experimental Scapular Therapeutic Exercise Group

All subjects will perform a program of scapular therapeutic exercises including: neuromuscular control/strength - scapular therapeutic exercises that leads to, at least, moderate muscular activity levels; and stretching exercises. The intervention period will be of 8 weeks, considering in-person and/or home sessions.

Sponsors & Collaborators

  • School of Health of Polytechnic Institute of Porto

    collaborator UNKNOWN

  • Center for Rehabilitation Research - Human Movement System (Re)habilitation Area

    collaborator UNKNOWN

  • Universidade do Porto

    collaborator OTHER

  • Porto Biomechanics Laboratory

    collaborator UNKNOWN

  • Center for Interdisciplinary Applied Research in Health, Health School of the Setubal, Polytechnic Institute

    collaborator UNKNOWN

  • Polytechnic Institute of Porto

    lead OTHER

Principal Investigators

  • Ana Melo · Polytechnic Institute of Porto

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-20
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05814978 on ClinicalTrials.gov